Vitaspring Biomedical (VSBC) Net Income towards Common Stockholders (2017 - 2026)
Vitaspring Biomedical (VSBC) reported Net Income towards Common Stockholders of -$155,817 for fiscal Q2 2027 (quarter ended Jul 31, 2026), compared with -$110,845 a year earlier.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, Vitaspring Biomedical's Net Income towards Common Stockholders came in at -$455,643; for FY2026 (ended Jan 31, 2026), it came in at -$415,368.
- By fiscal year, Net Income towards Common Stockholders came in at -$774,922 in FY2025, -$1.12 million in FY2024, -$4.16 million in FY2023 and $909,560 in FY2022.
- The fiscal Q2 2027 figure ranks as the lowest quarterly Net Income towards Common Stockholders since fiscal Q3 2025.
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -$75,844 (Q1 2027), -$81,464 (Q4 2026) and -$142,518 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - | -155,817.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -155,817.00 |
| Apr 30, 2026 | -75,844.00 |
| Jan 31, 2026 | -81,464.00 |
| Oct 31, 2025 | -142,518.00 |
| Jul 31, 2025 | -110,845.00 |
| Apr 30, 2025 | -80,541.00 |
| Jan 31, 2025 | -143,137.00 |
| Oct 31, 2024 | -196,292.00 |
| Jul 31, 2024 | -218,662.00 |
| Apr 30, 2024 | -216,831.00 |
| Jan 31, 2024 | -225,398.00 |
| Oct 31, 2023 | -234,980.00 |
| Jul 31, 2023 | -353,583.00 |
| Apr 30, 2023 | -304,601.00 |
| Jan 31, 2023 | -4.16 Mn |
| Oct 31, 2022 | -138,281.00 |
| Jul 31, 2022 | -144,135.00 |
| Apr 30, 2022 | 276,656.00 |
| Jan 31, 2022 | 1.23 Mn |
| Oct 31, 2021 | -137,453.00 |
API Access
Vitaspring Biomedical Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();